ОЦЕНКА ТЕРАПЕВТИЧЕСКОЙ ЭФФЕКТИВНОСТИ ВАРФАРИНА ПРОИЗВОДСТВА ЗАО «КАНОНФАРМА ПРАДАКШЕН» (РОССИЯ)
Warfarin by «Kanonpharma production» (Russia) and original Warfarin have the similar safety and tolerability. We need some increase of dose of Warfarin by «Kanonpharma production» to reach target rate of INR, then in case of original Warfarin usage. But for 1.5 month of treatment this characteristic...
Main Authors: | М. В. Хруслов, Е. В. Ройтман |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2014-02-01
|
Series: | Arhivʺ Vnutrennej Mediciny |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/262 |
Similar Items
-
Comparisons of Methods and Outcomes of Warfarin Guideline-based Management in Patients on Warfarin Therapy whose International Normalized Ratio (INR) is Higher than Target INR at Vachiraphuket Hospital
by: Tulaya Potaros, et al.
Published: (2018-08-01) -
The impact of aripiprazole on INR in a psychotic patient during warfarin therapy
by: Taha Can Tuman
Published: (2018-10-01) -
The progress of prothrombin time measurement
by: Juha Eero Horsti
Published: (2009-12-01) -
Moxifloxacin-warfarin interaction
by: Yan Ji, et al.
Published: (2012-01-01) -
Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
by: Eljilany I, et al.
Published: (2021-08-01)